Anavex Life Sciences Corp

NAS:AVXLHealthcareCBOEFTSE:MRUTNASDAQ:NBI

$1.25−4.58%At closeAt close · Tue 20 Oct · ≈ AED 4.59 · Market cap — · Next earnings Mon 30 Nov

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Return on equity	−96.5%	−25.1%	−33.7%	−33.5%	−35.8%	−48.9%	−48.9%	+0.0 pts
Return on assets	−76.1%	−23.5%	−31.4%	−30.8%	−31.7%	−44.7%	−44.7%	+0.0 pts
Return on capital employed	0.0%	−27.8%	−35.8%	−39.3%	−44.0%	−54.2%	—	—
Debt / equity	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	—
Debt / assets	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—
Interest coverage	0.0×	0.0×	0.0×	−57.8×	0.0×	0.0×	—	—
Current ratio	4.7×	15.0×	15.0×	12.3×	8.9×	11.6×	11.6×	+0.0%
Quick ratio	4.7×	15.0×	15.0×	12.3×	8.9×	11.6×	—	—
Cash ratio	4.0×	14.1×	14.6×	12.0×	8.6×	11.5×	11.5×	+0.0%
Asset turnover	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	—	—
Inventory turnover	—	0.0×	—	—	—	—	—	—
Receivables turnover	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—

Margins, returns, leverage and liquidityUpdated 30 Sep 2025 ·

ⓘ

Current snapshot ratios have no reporting date and are shown separately from fiscal periods.